Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urologic Neoplasms × Lidocaine × Clear all

Sponsor

Conditions

Prostatic Neoplasms 2 Neuralgia 2 Neoplasms 2 Lung Neoplasms 2 Leiomyoma 2 Sexual Dysfunction, Physiological 1 Scleroderma, Localized 1 Pneumonia 1 Pain 1 Neuropathy, Painful 1 Neurofibromatoses 1 Neurodermatitis 1 Neoplasms, Cystic, Mucinous, and Serous 1 Mastodynia 1 Lymphoma, Follicular 1 Lichen Planus 1 Leukemia-Lymphoma 1 Kidney Neoplasms 1 Keratoacanthoma 1 Keloid 1 Ileus 1 Hydrocephalus 1 Hordeolum 1 Headache 1 Granuloma Annulare 1 Eyelid Neoplasms 1 Epilepsy 1 Dermoid Cyst 1 Colorectal Neoplasms 1 Cold Hypersensitivity 1

Interventions

Trastuzumab 3 Sugammadex 2 Neostigmine 2 Cisplatin 2 valrubicin 1 tucatinib 1 pembrolizumab 1 niraparib 1 enfortumab vedotin 1 avelumab 1 atezolizumab 1 Surveys and Questionnaires 1 Sunitinib 1 Standard of Care 1 Rocuronium 1 Pemetrexed 1 Paclitaxel 1 Nephroureterectomy 1 Neoadjuvant Therapy 1 Mitomycin 1 Lymph Node Excision 1 Glycopyrrolate 1 Gemcitabine 1 GSK-3326595 1 Fulvestrant 1 Docetaxel 1 Cetuximab 1 Afatinib 1 Administration, Intravesical 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡